We invest in visionary teams with transformative ideas.

Join Canaan's extended family.
222
companies
930
Jobs
Theraclone Sciences
Theraclone Sciences
theraclone-sciences.com

Locations

Seattle, WA, USA

industry

Biotechnology · DeepTech · Health

Size

1 - 10 employees

Stage

Other

founded in

2004

Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for large-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.

Something looks off?
Open jobs at Theraclone Sciences
Powered by Getro